APODX TECHNOLOGY, INC.
Update：2026/09/15
Industries
Main Industry
Health Care
Main Product/Service
For a long time, cardiologists have primarily relied on data recorded by electrocardiogram (ECG) machines or used stethoscopes to listen to the sounds of the beating heart to make preliminary diagnoses of cardiac diseases. However, due to equipment limitations in the past, it was difficult to synchronously analyze and measure ECG and heart sound signals. Through technology licensing and collaboration with Inovise Medical, Inc. of the United States, APODX TECHNOLOGY, INC. has successfully developed the "Zhen-Tie-Xin" wearable medical device and fully mastered the world-leading coaxial automatic analysis technology for heart sounds and ECG.
General Manager Yang Zijie further stated, "This technology combines the hardware manufacturing strength of Leadtek Research Inc. with the data integration capabilities of amorRunner Cloud. We believe we can vigorously promote this detection technology, enabling more patients to receive early treatment or prevent the onset of illness, and even accurately track their recovery." It acts just like a "caring" guardian.
Multi-physiological Signal Acquisition Terminal - Zhen-Tie-Xin
1. Single-lead ECG signal: Provides analysis for arrhythmia and autonomic nervous system (HRV) health.
2. High-sensitivity heart sound collection: Provides assessment of cardiac systolic function and hemodynamics.
3. Chest wall movement/breathing sounds: Monitors respiration depth and snoring status.
4. Physical activity and posture: Tracks physical activity levels and sleep quality.
5. Wireless transmission or offline recording: Offers two usage modes—real-time monitoring or long-term recording and analysis.
6. High waterproof rating: Worry-free 24-hour wear.
(The content above was translated by AI.)
General Manager Yang Zijie further stated, "This technology combines the hardware manufacturing strength of Leadtek Research Inc. with the data integration capabilities of amorRunner Cloud. We believe we can vigorously promote this detection technology, enabling more patients to receive early treatment or prevent the onset of illness, and even accurately track their recovery." It acts just like a "caring" guardian.
Multi-physiological Signal Acquisition Terminal - Zhen-Tie-Xin
1. Single-lead ECG signal: Provides analysis for arrhythmia and autonomic nervous system (HRV) health.
2. High-sensitivity heart sound collection: Provides assessment of cardiac systolic function and hemodynamics.
3. Chest wall movement/breathing sounds: Monitors respiration depth and snoring status.
4. Physical activity and posture: Tracks physical activity levels and sleep quality.
5. Wireless transmission or offline recording: Offers two usage modes—real-time monitoring or long-term recording and analysis.
6. High waterproof rating: Worry-free 24-hour wear.
(The content above was translated by AI.)
Founded Year
2013
Unified Business No.
54647364
Status
Active
Number of Employees
0
Total Paid-in
Capital
16,600,000 (NT$)
Location of Company
Taiwan
, Taoyuan City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
APODX TECHNOLOGY, INC. is a platform service company dedicated to combining miniature physiological signal acquisition devices and cloud-based medical testing and analysis systems. Since its establishment, the company has focused on developing cloud diagnostic platforms that can assist professional physicians in making judgments and diagnoses. In the future, it hopes to continuously expand the platform's testing and analysis capabilities with more innovative technologies to serve more people in need of care.
(The content above was translated by AI.)
(The content above was translated by AI.)
